Difference between revisions of "Leadership"
| [checked revision] | [checked revision] |
| Line 10: | Line 10: | ||
File:Malini Sathanoori.jpg|Malini Sathanoori, PhD, FACMG, Senior Cytogenetics Director, Quest Diagnostics, Chantilly VA; '''[mailto:msathanoori@yahoo.com <u>msathanoori@yahoo.com</u>]'''; '''Associate Editor CCGA [AML Section'''<nowiki>]</nowiki> | File:Malini Sathanoori.jpg|Malini Sathanoori, PhD, FACMG, Senior Cytogenetics Director, Quest Diagnostics, Chantilly VA; '''[mailto:msathanoori@yahoo.com <u>msathanoori@yahoo.com</u>]'''; '''Associate Editor CCGA [AML Section'''<nowiki>]</nowiki> | ||
File:Church Alanna picture.jpg|Alanna Church, MSc, MD, FRCPC, Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP), Boston Children’s Hospital, Assistant Professor of Pathology, Harvard Medical School; '''[mailto:Alanna.Church@childrens.harvard.edu <u>Alanna.Church@childrens.harvard.edu</u>]'''; '''Associate Editor CCGA [Gene-Specific Section]''' | File:Church Alanna picture.jpg|Alanna Church, MSc, MD, FRCPC, Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP), Boston Children’s Hospital, Assistant Professor of Pathology, Harvard Medical School; '''[mailto:Alanna.Church@childrens.harvard.edu <u>Alanna.Church@childrens.harvard.edu</u>]'''; '''Associate Editor CCGA [Gene-Specific Section]''' | ||
| + | File:Laveniya Satgunaseelan.jpg|Laveniya Satgunaseelan, MBBS, FRCPA, Staff Specialist Neuropathologist, Department of Neuropathology, Royal Prince Alfred Hospital (Sydney, Australia); '''[mailto:Laveniya.Satgunaseelan@health.nsw.gov.au <u>Laveniya.Satgunaseelan@health.nsw.gov.au</u>]''';'''Associate Editor CCGA [CNS book]''' | ||
</gallery> | </gallery> | ||
Revision as of 08:31, 25 April 2022
Meet your editors! We welcome questions and your participation in the CCGA.
Jennelle C. Hodge, PhD, FACMG, Professor, Department of Medical and Molecular Genetics, Indiana University; jhodge1@iu.edu; Editor-in-Chief CCGA
Kilannin Krysiak, PhD, Assistant Professor, Department of Pathology and Immunology, Washington University School of Medicine; kkrysiak@wustl.edu; Technical Editor CCGA
Fabiola-Quintero-Rivera, MD, Professor, Departments of Pathology and Laboratory Medicine and Pediatrics, University of California Irvine; fabiolaq@hs.uci.edu; Associate Editor CCGA [MDS/MPN Section]
Yassmine Akkari, PhD, FACMG, Scientific Director of Cytogenetics and Molecular Pathology, Manager of Genetics Laboratories Operations, Legacy Health; yassmineakkari@outlook.com; Associate Editor CCGA [ALL Section]
Snehal Patel, MD, PhD; sbpatel2009@gmail.com; Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Mature T- and NK-cell Neoplasms Section]
Greg Corboy, PhD, Pathology Queensland (Queensland, Australia) School of Clinical Sciences, Monash University (Melbourne, Australia), Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia); gregcorboy@bigpond.com; Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Hodgkin Lymphomas/Lymphoproliferative Disorders/Other Rare Entities Section]
Malini Sathanoori, PhD, FACMG, Senior Cytogenetics Director, Quest Diagnostics, Chantilly VA; msathanoori@yahoo.com; Associate Editor CCGA [AML Section]
Alanna Church, MSc, MD, FRCPC, Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP), Boston Children’s Hospital, Assistant Professor of Pathology, Harvard Medical School; Alanna.Church@childrens.harvard.edu; Associate Editor CCGA [Gene-Specific Section]
Laveniya Satgunaseelan, MBBS, FRCPA, Staff Specialist Neuropathologist, Department of Neuropathology, Royal Prince Alfred Hospital (Sydney, Australia); Laveniya.Satgunaseelan@health.nsw.gov.au;Associate Editor CCGA [CNS book]
